Iron-laden blasts in refractory acute myeloid leukemia

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
Online-Ressource, 1 online resource.
Language
Englisch

Bibliographic citation
Iron-laden blasts in refractory acute myeloid leukemia ; volume:16 ; number:3 ; day:29 ; month:7 ; year:2023 ; pages:187-188 ; date:9.2023
Journal of hematopathology ; 16, Heft 3 (29.7.2023), 187-188, 9.2023

Creator
Vossen, Christopher
Im, Roeun
Horna, Pedro
Contributor
SpringerLink (Online service)

DOI
10.1007/s12308-023-00555-6
URN
urn:nbn:de:101:1-2023110608535946247895
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:45 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Vossen, Christopher
  • Im, Roeun
  • Horna, Pedro
  • SpringerLink (Online service)

Other Objects (12)

Timed Sequential Salvage Chemotherapy for Relapsed or Refractory Acute Myeloid Leukemia

Timed Sequential Salvage Chemotherapy for Relapsed or Refractory Acute Myeloid Leukemia

Use of cellular immunotherapy for treatment of refractory acute myeloid leukemia

Use of cellular immunotherapy for treatment of refractory acute myeloid leukemia

Venetoclax combined with FLAG-IDA in refractory or relapsed acute myeloid leukemia

Venetoclax combined with FLAG-IDA in refractory or relapsed acute myeloid leukemia

B Cell Deficiency in Patients with Relapsed and Refractory Acute Myeloid Leukemia

B Cell Deficiency in Patients with Relapsed and Refractory Acute Myeloid Leukemia

Discovery of imatinib-responsive FIP1L1-PDGFRA mutation during refractory acute myeloid leukemia transformation of chronic myelomonocytic leukemia

Discovery of imatinib-responsive FIP1L1-PDGFRA mutation during refractory acute myeloid leukemia transformation of chronic myelomonocytic leukemia

Concentration–QTc analysis of quizartinib in patients with relapsed/refractory acute myeloid leukemia

Concentration–QTc analysis of quizartinib in patients with relapsed/refractory acute myeloid leukemia

Venetoclax-Azacitidine Bridging PTCy-haplo-PBSCT for Refractory Acute Myeloid Leukemia with IDH2 Mutations

Venetoclax-Azacitidine Bridging PTCy-haplo-PBSCT for Refractory Acute Myeloid Leukemia with IDH2 Mutations

Gilteritinib versus chemotherapy in Japanese patients with FLT3-mutated relapsed/refractory acute myeloid leukemia

Gilteritinib versus chemotherapy in Japanese patients with FLT3-mutated relapsed/refractory acute myeloid leukemia

The clinical significance of iron overload and iron metabolism in myelodysplastic syndrome and acute myeloid leukemia

The clinical significance of iron overload and iron metabolism in myelodysplastic syndrome and acute myeloid leukemia

Clinical experience with venetoclax in patients with newly diagnosed, relapsed, or refractory acute myeloid leukemia

Clinical experience with venetoclax in patients with newly diagnosed, relapsed, or refractory acute myeloid leukemia

Clinical experience with venetoclax in patients with newly diagnosed, relapsed, or refractory acute myeloid leukemia

Clinical experience with venetoclax in patients with newly diagnosed, relapsed, or refractory acute myeloid leukemia

Pregnancy with acute myeloid leukemia

Pregnancy with acute myeloid leukemia

Related objects